Baidu’s AI Chip Unit Kunlunxin Prepares for Hong Kong IPO to Raise Up to $2 Billion 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
Samsung to Double AI-Powered Mobile Devices with Google Gemini in Global AI Race 
Discord Confidentially Files for U.S. IPO, Signaling Major Milestone 
Nvidia Unveils Rubin Platform to Power Next Wave of AI Infrastructure 
Samsung Electronics Hits Record High as AI Momentum Fuels Investor Optimism 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
TSMC Shares Hit Record High as Goldman Sachs Raises Price Target on AI Demand Outlook 
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 
Grok AI Controversy on X Sparks Global Outrage Over Nonconsensual Images 
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Reddit Emerges as a Major Winner in the Shift to AI-Powered Search 
AMD Unveils Next-Generation AI and PC Chips at CES, Highlights Major OpenAI Partnership 
China Reviews Meta’s $2 Billion AI Deal With Manus Amid Technology Control Concerns 
Today, the United States International Trade Commission (ITC) formally opposed Apple's move to keep the Apple Watch sales restriction in place for the length of its appeal.
ITC Wants Apple Watch Sales Ban Reinstated
In a document filed with the United States in the Court of Appeals for the Federal Circuit, ITC lawyers stated that "Apple presents a weak and unconvincing case to invoke the extraordinary remedy of a stay pending appeal," and that Apple's arguments "amount to little more than an indisputably adjudicated infringer requesting permission to continue infringing the asserted patents."
The court is seeking responses from other parties in support of the ITC's decision until January 15, so the Apple Watch should be available until early next week at the very least, as per MacRumors.
In October, the ITC determined that Apple Watch models with blood oxygen sensing infringed on Masimo's patents, and as a result, the import and sale of these devices in the United States was prohibited. The feature is accessible on Apple Watch Series 6 and later, excluding Apple Watch SE devices.
Masimo has accused Apple of stealing trade secrets and poaching staff to develop blood oxygen-detecting technology. Last month, Masimo stated that it was open to settlement talks, but Apple reportedly showed little interest at the time.
Apple Awaits Customs Ruling on Software Updates
In December, Apple temporarily halted sales of the Apple Watch Series 9 and Apple Watch Ultra 2 in its retail and online locations in the United States. After appealing the ITC's ruling to the U.S. Apple was given a temporary stay by the Court of Appeals for the Federal Circuit, which halted the ban and allowed sales to resume for the time being, according to The Verge.
Apple is purportedly developing software updates to address the alleged patent violation and the U.S. The Customs and Border Protection Agency is anticipated to rule on these adjustments later this week. However, Masimo feels that the Apple Watch's hardware design must change in order to be compatible, and the ITC has also expressed concern.
Photo: Simon Daoudi/Unsplash
